Levosalbutamol Withdrawn Phase 4 Trials for Asthma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00830882Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol